166 related articles for article (PubMed ID: 19724898)
1. Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Int J Mol Med; 2009 Oct; 24(4):563-9. PubMed ID: 19724898
[TBL] [Abstract][Full Text] [Related]
2. Association between IL-17A, -17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Int J Mol Med; 2010 Mar; 25(3):471-7. PubMed ID: 20127054
[TBL] [Abstract][Full Text] [Related]
3. Effect of polymorphisms of IL-1β and TNF-α genes on CpG island hyper methylation (CIHM) in the nonneoplastic gastric mucosa.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Hirata I; Arisawa T
Mol Carcinog; 2011 Nov; 50(11):835-45. PubMed ID: 21400614
[TBL] [Abstract][Full Text] [Related]
4. Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa.
Takano H; Shibata T; Nakamura M; Sakurai N; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Otsuka T; Tahara T; Arisawa T
BMC Med Genet; 2020 Oct; 21(1):205. PubMed ID: 33066747
[TBL] [Abstract][Full Text] [Related]
5. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Digestion; 2010; 82(1):27-36. PubMed ID: 20150736
[TBL] [Abstract][Full Text] [Related]
6. Influence of MIF polymorphisms on CpG island hyper-methylation of CDKN2A in the patients with ulcerative colitis.
Sakurai N; Shibata T; Nakamura M; Takano H; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Ostuka T; Tahara T; Arisawa T
BMC Med Genet; 2020 Oct; 21(1):201. PubMed ID: 33046033
[TBL] [Abstract][Full Text] [Related]
7. Chronic nonsteroidal anti-inflammatory drug (NSAID) use suppresses multiple CpG islands hyper methylation (CIHM) of tumor suppressor genes in the human gastric mucosa.
Tahara T; Shibata T; Yamashita H; Nakamura M; Yoshioka D; Okubo M; Hirata I; Arisawa T
Cancer Sci; 2009 Jul; 100(7):1192-7. PubMed ID: 19432886
[TBL] [Abstract][Full Text] [Related]
8. Association between cyclin D1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Dig Dis Sci; 2010 Dec; 55(12):3449-57. PubMed ID: 20397048
[TBL] [Abstract][Full Text] [Related]
9. Association between polymorphisms in the XRCC1 and GST genes, and CpG island methylation status in colonic mucosa in ulcerative colitis.
Tahara T; Shibata T; Nakamura M; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Hirata I; Arisawa T
Virchows Arch; 2011 Feb; 458(2):205-11. PubMed ID: 21234761
[TBL] [Abstract][Full Text] [Related]
10. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk.
Kaise M; Yamasaki T; Yonezawa J; Miwa J; Ohta Y; Tajiri H
Helicobacter; 2008 Feb; 13(1):35-41. PubMed ID: 18205664
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of DNA repair and xenobiotic genes predispose to CpG island methylation in non-neoplastic gastric mucosa.
Tahara T; Shibata T; Nakamura M; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Ishizuka T; Hirata I; Arisawa T
Helicobacter; 2011 Apr; 16(2):99-106. PubMed ID: 21435086
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of molecules associated with inflammation and immune response in Japanese subjects with functional dyspepsia.
Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
Int J Mol Med; 2007 Nov; 20(5):717-23. PubMed ID: 17912466
[TBL] [Abstract][Full Text] [Related]
13. CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer.
Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I
Anticancer Res; 2010 Jan; 30(1):239-44. PubMed ID: 20150642
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis.
Shibata T; Tahara T; Hirata I; Arisawa T
Hum Immunol; 2009 Jul; 70(7):547-51. PubMed ID: 19414056
[TBL] [Abstract][Full Text] [Related]
15. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis.
Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Nakamura M; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
J Clin Immunol; 2008 Jan; 28(1):44-9. PubMed ID: 17828618
[TBL] [Abstract][Full Text] [Related]
16. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
[TBL] [Abstract][Full Text] [Related]
17. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
18. Impact of catechol-O-methyltransferase (COMT) gene polymorphism on promoter methylation status in gastric mucosa.
Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nagasaka M; Iwata M; Takahama K; Watanabe M; Hirata I
Anticancer Res; 2009 Jul; 29(7):2857-61. PubMed ID: 19596974
[TBL] [Abstract][Full Text] [Related]
19. MTHFR 677T carrier influences the methylation status of H. pylori-infected gastric mucosa in older subjects.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Takahama K; Watanabe M; Hirata I; Arisawa T
Dig Dis Sci; 2009 Nov; 54(11):2391-8. PubMed ID: 19082889
[TBL] [Abstract][Full Text] [Related]
20. Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer.
Wu X; Zeng Z; Chen B; Yu J; Xue L; Hao Y; Chen M; Sung JJ; Hu P
Int J Cancer; 2010 Jul; 127(1):86-92. PubMed ID: 19904747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
